apollo
0

Welcome User

Login/Sign Up

Home
Buy Medicines
Lab Tests
Doctor Consult
Circle Membership
insurance
Blogs
Contact Us
Privacy Policy
Return & Refunds
Need Help
Terms and Conditions
  1. Home
  2. Medicine

  3. Fulvaa 250 mg Prefilled Syringe Injection 5 ml

Fulvaa 250 mg Prefilled Syringe Injection 5 ml, Pack of 1
Offers on medicine orders
All offers
axis icici
Written By Veda Maddala , M Pharmacy
Reviewed By Dr Aneela Siddabathuni , MPharma., PhD

Fulvaa 250 mg Prefilled Syringe Injection 5 ml is used to treat breast cancer in postmenopausal women. It contains Fulvestrant, which works by inhibiting some of the actions of estrogen (female sex hormone which may help cancer cells grow in women with breast cancer) and reducing the amount that is in the body. Thus, it helps in reducing breast cancer tumour growth. In some cases, Fulvaa 250 mg Prefilled Syringe Injection 5 ml may cause certain common side effects such as injection site reactions like pain and/or inflammation, weakness, nausea, tiredness, headache or joint and musculoskeletal pain.

Read more
rxMedicinePrescription drug

Whats That

tooltip

Also Explore

Momverse
Ask Apollo
insurance

Composition :

FULVESTRANT-250MG

Manufacturer/Marketer :

Shilpa Medicare Ltd

Consume Type :

PARENTERAL

Return Policy :

Not Returnable

Expires on or after :

About Fulvaa 250 mg Prefilled Syringe Injection 5 ml

Fulvaa 250 mg Prefilled Syringe Injection 5 ml belongs to the class of estrogen blockers used to treat breast cancer in postmenopausal women. Breast cancer is a type of cancer that develops when the breast cells begin to grow abnormally.

Fulvaa 250 mg Prefilled Syringe Injection 5 ml contains Fulvestrant, which works by inhibiting some of the actions of estrogen (female sex hormone which may help cancer cells grow in women with breast cancer) and reducing the amount that is in the body. Thus, it helps in reducing breast cancer tumour growth.

Fulvaa 250 mg Prefilled Syringe Injection 5 ml will be administered by a healthcare professional; do not self-administer. In some cases, Fulvaa 250 mg Prefilled Syringe Injection 5 ml may cause certain common side effects such as injection site reactions like pain and/or inflammation, weakness, nausea, tiredness, headache or joint and musculoskeletal pain. Most of these side effects of Fulvaa 250 mg Prefilled Syringe Injection 5 ml do not require medical attention and gradually resolve over time. However, if these side effects persist or worsen, please consult your doctor.

If you are allergic to Fulvestrant or any other medicines, please tell your doctor. Fulvaa 250 mg Prefilled Syringe Injection 5 ml is not recommended for pregnant women as it may harm an unborn baby. Fulvaa 250 mg Prefilled Syringe Injection 5 ml is contraindicated for use during lactation. Avoid alcohol consumption while receiving Fulvaa 250 mg Prefilled Syringe Injection 5 ml. Avoid driving or operating machinery if you feel tired or weak after receiving Fulvaa 250 mg Prefilled Syringe Injection 5 ml.

Uses of Fulvaa 250 mg Prefilled Syringe Injection 5 ml

Fulvaa 250 mg Prefilled Syringe Injection 5 ml is used in the treatment of Breast cancer in postmenopausal women. The detailed uses of Fulvaa 250 mg Prefilled Syringe Injection 5 ml are as follows:<br/>• Treatment of breast cancer: Fulvaa 250 mg Prefilled Syringe Injection 5 ml is used in the treatment of hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancer in postmenopausal women.<br/>• Treatment of progressed cancer: Fulvaa 250 mg Prefilled Syringe Injection 5 ml is prescribed when the cancer has progressed following prior endocrine therapy.<br/>

Directions for Use

• Your doctor will decide the dosage and timing of Fulvaa 250 mg Prefilled Syringe Injection 5 ml based on the stage of cancer and your body's response to the treatment. Usually, it is given every two weeks for the first three doses, then once monthly.• Fulvaa 250 mg Prefilled Syringe Injection 5 ml will be administered by a doctor or nurse in a medical facility.• Do not self-administer.

Medicinal Benefits

Fulvaa 250 mg Prefilled Syringe Injection 5 ml contains Fulvestrant, used to treat breast cancer in postmenopausal women. Additionally, Fulvaa 250 mg Prefilled Syringe Injection 5 ml may be used in combination with palbociclib to treat women with a type of breast cancer called hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that is locally advanced or has spread to other parts of the body (metastatic).

How Fulvaa 250 mg Prefilled Syringe Injection 5 ml Works

Fulvaa 250 mg Prefilled Syringe Injection 5 ml contains Fulvestrant, which works by inhibiting some of the actions of estrogen (female sex hormone which may help cancer cells grow in women with breast cancer) and reducing the amount that is in the body. Thus, it helps in reducing breast cancer tumour growth.

Storage

• Store in a cool and dry place away from sunlight.• Keep Fulvaa 250 mg Prefilled Syringe Injection 5 ml out of reach and sight of children.• Cold chain - To be stored in cold places at 2ºC to 8ºC.

What if I have taken an overdose of Fulvaa 250 mg Prefilled Syringe Injection 5 ml

As Fulvaa 250 mg Prefilled Syringe Injection 5 ml is a parenteral formulation administered by experienced medical staff, the chance of overdose may be less. If you think there has been an overdose or experiencing any adverse events, get medical care right away. In a medical setting, an overdose would be treated quickly.

Drug Warnings

If you are allergic to Fulvestrant or any other medicines, please tell your doctor. Fulvaa 250 mg Prefilled Syringe Injection 5 ml is not recommended for pregnant women as it may harm an unborn baby. Using effective contraception while being treated with Fulvaa 250 mg Prefilled Syringe Injection 5 ml and for two years after the last dose is advised. Fulvaa 250 mg Prefilled Syringe Injection 5 ml is contraindicated for use during lactation. Avoid alcohol consumption while receiving Fulvaa 250 mg Prefilled Syringe Injection 5 ml. Avoid driving or operating machinery if you feel tired or weak after receiving Fulvaa 250 mg Prefilled Syringe Injection 5 ml.

Diet & Lifestyle Advise

  • Avoid fried and processed foods.
  • Include fibre-rich foods such as whole grains, fruits, and vegetables in your diet.
  • Avoid refined carbohydrates that are high in sugars.
  • Replace animal proteins (like eggs, fish, and meat) with vegetable protein sources (nuts, seeds, and beans).
  • Avoid drinking excess alcohol or caffeinated drinks, as they can worsen the symptoms.
  • Maintain a healthy weight and do moderate exercise regularly.
  • Avoid smoking and alcohol intake.

Habit Forming

No

Therapeutic Class

ANTINEOPLASTIC

Fulvaa 250 mg Prefilled Syringe Injection 5 ml Substitute

Substitutes safety advice

Product Substitutes

bannner image

Alcohol

Caution

Avoid alcohol consumption while receiving this medicine. If you have any concerns, please discuss them with your doctor.

bannner image

Pregnancy

Unsafe

Fulvaa 250 mg Prefilled Syringe Injection 5 ml is not recommended for use during pregnancy as it may harm the unborn baby. You are advised to use effective contraception while being treated with Fulvaa 250 mg Prefilled Syringe Injection 5 ml and for two years after your last dose.

bannner image

Breast Feeding

Unsafe

Fulvaa 250 mg Prefilled Syringe Injection 5 ml is contraindicated for use during lactation, or you are recommended to avoid breastfeeding while on treatment with Fulvaa 250 mg Prefilled Syringe Injection 5 ml.

bannner image

Driving

Safe if prescribed

Fulvaa 250 mg Prefilled Syringe Injection 5 ml usually does not affect your ability to drive or operate machinery. However, avoid driving or operating machinery if you feel tired or weak after receiving Fulvaa 250 mg Prefilled Syringe Injection 5 ml.

bannner image

Liver

Caution

Fulvaa 250 mg Prefilled Syringe Injection 5 ml is not recommended for patients with severe liver problems. Therefore, if you have liver problems, inform your doctor before receiving Fulvaa 250 mg Prefilled Syringe Injection 5 ml.

bannner image

Kidney

Caution

If you have kidney problems, inform your doctor before receiving Fulvaa 250 mg Prefilled Syringe Injection 5 ml.

bannner image

Children

Unsafe

Fulvaa 250 mg Prefilled Syringe Injection 5 ml is not recommended for children and adolescents below 18 years of age.

Have a query?

FAQs

Fulvaa 250 mg Prefilled Syringe Injection 5 ml is used to treat Breast cancer in postmenopausal women.

Fulvaa 250 mg Prefilled Syringe Injection 5 ml contains Fulvestrant which works by inhibiting some of the actions of estrogen (female sex hormone) and reducing the amount that is in the body. Thus, it helps in reducing breast cancer tumour growth.

Fulvaa 250 mg Prefilled Syringe Injection 5 ml is not recommended for patients with severe liver problems. Therefore, if you have any liver problems, inform your doctor before receiving Fulvaa 250 mg Prefilled Syringe Injection 5 ml.

Fulvaa 250 mg Prefilled Syringe Injection 5 ml may cause weakness or tiredness as a common side effect. However, if weakness persists or worsens, please consult your doctor.

Fulvaa 250 mg Prefilled Syringe Injection 5 ml contains Fulvestrant, which belongs to a class of medications called estrogen receptor antagonists. It helps to slow or stop the growth of specific breast tumours that depend on estrogen (a female sex hormone) to grow.

Fulvaa 250 mg Prefilled Syringe Injection 5 ml is administered as a liquid injection into a muscle in the buttocks by a doctor in a medical setting. It is typically injected slowly over 1 to 2 minutes. For the first three doses, you will receive an injection every two weeks (on days 1, 15, and 29). After that, it is usually given once a month. Your doctor will determine the exact schedule based on your condition and how you respond to the medication. The injection will be given as two separate shots (one in each buttock). Please do not self-administer it.

Fulvaa 250 mg Prefilled Syringe Injection 5 ml may cause common side effects, such as injection site reactions like pain and inflammation, weakness, nausea, tiredness, headache, or joint and musculoskeletal pain in some individuals. Most of these side effects of Fulvaa 250 mg Prefilled Syringe Injection 5 ml do not require medical attention and gradually resolve over time. However, if these side effects persist or worsen, please consult your doctor.

Country of origin

India

Manufacturer/Marketer address

709, 7Th Floor, Palm Spring Center, Link Road, Malad West, Mumbai- 400064
Other Info - FUL0285

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.

Author Details

Veda MaddalaDoctor badge

Written By

Veda Maddala

M Pharmacy

Dr Aneela SiddabathuniDoctor badge

Reviewed By

Dr Aneela Siddabathuni

MPharma., PhD

Last Updated

Jul 18, 2025 | 7:05 AM IST

Doctor imageWe provide you with authentic, trustworthy and relevant information

Reference

  1. https://www.medicines.org.uk/emc/product/68/pil
  2. https://www.astrazeneca.ca/content/dam/az-ca/downloads/productinformation/faslodex-consumer-information-leaflet-en.pdf
  3. https://www.medsafe.govt.nz/consumers/cmi/f/faslodex.pdf

Buy best Neoplastic Disorders products by

whatsapp Floating Button